BMF anticorps
Aperçu rapide pour BMF anticorps (ABIN187548)
Antigène
Voir toutes BMF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Specificité
- Recognizes human and mouse Bmf. Species Reactivity: Human and mouse. Others not tested.
-
Immunogène
- Recombinant mouse Bmf fused to glutathione-S-transferase (GST).
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Western blot: Use at 0.5-1.0 µg/mL Flow cytometry: Use at 1-10 µg/mL (1:100- 1:1,000 dilution) Immunoprecipitation: Use at 2-5 µg/mL The optimal dilution for a specific application should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 100 µg of protein G purified antibody in PBS containing 0.02% sodium azide. Concentration is 1 mg/mL.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
-
- BMF (Bcl2 Modifying Factor (BMF))
-
Autre désignation
- BMF
-
Sujet
- Bmf is a novel BH3-only protein that was discovered in a yeast 2-hybrid library screen with Mcl-1 (a pro-survival member of the Bcl-2 family) as the target molecule. Biochemical experiments demonstrated that Bmf binds to Bcl-2 and all of its pro-survival homologs through its BH3 domain. Co-immunoprecipitation of Bmf and Bcl-2 can be detected in cells that express both proteins at physiological levels. Bmf promotes apoptosis by blocking the pro-survival activity of Bcl-2 and its homologs. In healthy cells, Bmf is sequestered to the actin cytoskeleton, via dynein light chain 2 (DLC2), allowing it to translocate and bind Bcl-2 and its homologs.
Antigène
-